Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2026-03-19 @ 10:41 PM
Study NCT ID:
NCT05523895
Status:
COMPLETED
Last Update Posted:
2025-08-24
First Post:
2022-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder
Sponsor:
ACADIA Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-27
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-29
First Submit QC Date:
None
Study First Post Date:
2022-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-08-07
Results First Submit QC Date:
None
Results First Post Date:
2025-08-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-07
Last Update Post Date:
2025-08-24
Last Update Post Date Type:
ACTUAL